Trial intelligence / Profile preview

Influence of erythromycin and bitter administration on ad libitum food intake

2013-004332-29Phase 4Completed

Sponsor
UZ Leuven
Start
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of erythromycin in obesity and None (2 arms), sponsored by UZ Leuven. Started Oct 2013; status: completed.

02

Drugs

erythromycin
03

Conditions

obesity

Beyond the preview

Go deeper on 2013-004332-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-004332-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call